NEU neuren pharmaceuticals limited

Ann: Change in substantial holding, page-10

  1. 5,523 Posts.
    lightbulb Created with Sketch. 1312
    Translated

    Hello,

    This is precisely the key question and ergo:

    the junction from which the near future of the NEU shareholding will be determined is based on what and what institutional figures will come into play in the title both directly and indirectly on the market as on 20 December last. the distinction that must be made is between mutual found and speculative institutional; the first by their nature have medium to long-term objectives and will evaluate entry into the stock only if this company will serve a break event by means of Trofinetide with dividend guarantee for shareholders. the latter will act to guarantee excellent profits in prospect or bet of a thriving agreement or acquisition.
    from the identity of this new institutional figure that has acquired in a single block almost 2% of the company, disbursing about 6 million dollars, maybe we will have the opportunity to understand what game we will play in the next few months on the NEU title.

    ciaoo
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.